RNA polymerase - An important molecular target of triptolide in cancer cells

被引:59
作者
Pan, Jingxuan [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou 510089, Guangdong, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
Triptolide; RNA polymerase; Molecular target; Cancer; CHRONIC MYELOGENOUS LEUKEMIA; TRIPTERYGIUM-WILFORDII HOOK; HUMAN MAST-CELLS; ONCOGENE ADDICTION; BCR-ABL; TUMOR-CELLS; APOPTOSIS; INHIBITORS; PROTEIN; KIT;
D O I
10.1016/j.canlet.2009.11.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Triptolide, a diterpenoid triepoxide, is the key biological component of Tripterygium wilfordu Hook. f which was used in traditional Chinese medicine for centuries to treat inflammation anti autoimmune diseases Triptolide has shown potent activity in not only anti-inflammation and immune modulation, but also antiproliferative and proapoptotic activity in many different types of cancer cells However, for a long time, the precise molecular target(s) of triptolide have remained elusive Recently, several groups discovered that triptolide inhibited the activity of RNA polymerase. This review will focus on these breakthrough findings about the molecular target of triptolide and its implications for targeted-cancer therapeutics. (C) 2009 Elseviei Ireland Ltd All rights reserved
引用
收藏
页码:149 / 152
页数:4
相关论文
共 45 条
  • [1] Fluorination of triptolide and its analogues and their cytotoxicity
    Aoyagi, Yutaka
    Hitotsuyanagi, Yukio
    Hasuda, Tomoyo
    Matsuyama, Saki
    Fukaya, Haruhiko
    Takeya, Koichi
    Aiyama, Ritsuo
    Matsuzaki, Takeshi
    Hashimoto, Shusuke
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (07) : 2459 - 2463
  • [2] Treating cancer's kinase 'addiction'
    Baselga, J
    Arribas, J
    [J]. NATURE MEDICINE, 2004, 10 (08) : 786 - 787
  • [3] Tliptolide induces caspase-dependent cell death mediated via the mitochondfial pathway in leukemic cells
    Carter, Bing Z.
    Mak, Duncan H.
    Schober, Wendy D.
    McQueen, Teresa
    Harris, David
    Estrov, Zeev
    Evans, Randall L.
    Andreeff, Michael
    [J]. BLOOD, 2006, 108 (02) : 630 - 637
  • [4] Chan EWC, 2001, TOXICOL LETT, V122, P81
  • [5] Triptolide inhibits Jak2 transcription and induces apoptosis in human myeloproliferative disorder cells bearing Jak2V617F through caspase-3-mediated cleavage of Mcl-1
    Chen, Qi
    Lu, Zhongzheng
    Jin, Yanli
    Wu, Yongbin
    Pan, Jingxuan
    [J]. CANCER LETTERS, 2010, 291 (02) : 246 - 255
  • [6] A sequential blockade strategy for the design of combination therapies to overcome oncogene addiction in chronic myelogenous leukemia
    Chen, Rong
    Gandhi, Varsha
    Plunkett, William
    [J]. CANCER RESEARCH, 2006, 66 (22) : 10959 - 10966
  • [7] Triptolide exerts anti-tumor effect on oral cancer and KB cells in vitro and in vivo
    Chen, Yuan-Wu
    Lin, Gu-Jiun
    Chia, Wei-Tso
    Lin, Chih-Kung
    Chuang, Yi-Ping
    Sytwu, Huey-Kang
    [J]. ORAL ONCOLOGY, 2009, 45 (07) : 562 - 568
  • [8] Characterisation of Mcl-1 cleavage during apoptosis of haematopoietic cells
    Clohessy, JG
    Zhuang, JG
    Brady, HJM
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (05) : 655 - 665
  • [9] Molecular understanding and modern application of traditional medicines: Triumphs and trials
    Corson, Timothy W.
    Crews, Craig M.
    [J]. CELL, 2007, 130 (05) : 769 - 774
  • [10] Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation
    Dewaele, Barbara
    Wasag, Bartosz
    Cools, Jan
    Sciot, Raf
    Prenen, Hans
    Vandenberghe, Peter
    Wozniak, Agnieszka
    Schoffski, Patrick
    Marynen, Peter
    Debiec-Rychter, Maria
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (18) : 5749 - 5758